Position in LUNG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,402
+$141 QoQ
Shares Held
14,156
0.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 107 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LUNG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $559,702,151 across 32 Medical Devices names. LUNG ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
5,343,777 | $228,072,401 | |
| 2 | SYK |
Stryker Corp
|
545,871 | $171,862,025 | |
| 3 | MDT |
Medtronic plc
|
922,752 | $72,186,888 | |
| 4 | DXCM |
Dexcom Inc
|
127,943 | $8,616,961 | |
| 5 | GMED |
Globus Medical Inc
|
103,160 | $8,150,671 | |
| 6 | TMDX |
TransMedics Group, Inc.
|
92,549 | $6,147,104 | |
| 7 | PODD |
Insulet Corp
|
35,853 | $5,458,619 | |
| 8 | LIVN |
LivaNova PLC
|
63,472 | $5,219,302 |
All Filings in LUNG
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,402 | 14,156 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,261 | 14,156 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,284 | 14,156 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $5 | 2,144 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $657,245 | 97,659 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $67,872 | 9,996 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $80,678 | 9,732 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||